General presentation of Moderna
Here, you can check out the Moderna Company and its main activities, in order to better understand how its economic environment is likely to impact its development on the stock market.
The Moderna Therapeutics group is an American company specializing in the biotechnology sector. More specifically, the company is invested in transformative medicines based on messenger RNA or mRNA. The company has even created a platform to improve the underlying pharmaceutical properties of mRNA-based drugs.
The platform focuses on three main areas:
- mRNA Technology
- Administration technologies
- Production Process
The group is pursuing mRNA science in order to reduce unwanted activation of the immune system by mRNA and promote the potency of mRNA once in target cells. The company is also pushing forward a development pipeline of 21 different programs, 10 of which are currently in clinical studies and three have open INDs.
Among the vaccine and therapy development programs are solutions for infectious diseases, oncology, cardiovascular disease and rare genetic diseases. They are broken down into six different methods with prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, local regenerative therapies, secreted systemic therapies and intracellular systemic therapies.
An important element to mention is that Moderna is currently in the process of developing a vaccine against Covid-19.
The group employs 830 people, mainly in the United States.
76.4% of retail investor accounts lose money when trading CFDs with this provider. Trade CFDs with Plus500